Central Drugs Standard Control Organisation

From Bharatpedia, an open encyclopedia
Information red.svg
Scan the QR code to donate via UPI
Dear reader, We need your support to keep the flame of knowledge burning bright! Our hosting server bill is due on June 1st, and without your help, Bharatpedia faces the risk of shutdown. We've come a long way together in exploring and celebrating our rich heritage. Now, let's unite to ensure Bharatpedia continues to be a beacon of knowledge for generations to come. Every contribution, big or small, makes a difference. Together, let's preserve and share the essence of Bharat.

Thank you for being part of the Bharatpedia family!
Please scan the QR code on the right to donate.

0%

   

transparency: ₹0 raised out of ₹100,000 (0 supporter)



Central Drugs Standard Control Organisation
File:Central Drugs Standard Control Organization.jpg
Organisation overview
TypeRegulatory body
HeadquartersNew Delhi, India
Coordinates: 28°37′56″N 77°14′08″E / 28.632309°N 77.235531°E / 28.632309; 77.235531
Annual budget₹3,358 crore (US$470 million) Decrease (2021 - 2022) [1]
Minister responsible
Organisation executive
  • Dr. V. G. Somani, Drugs Controller General of India
Parent departmentDirectorate General of Health Services, Ministry of Health and Family Welfare
Websitecdsco.gov.in and www.cdscoonline.gov.in

The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. It serves a similar function to the European Medicines Agency of the European Union, the PMDA of Japan, the Food and Drug Administration (FDA) of the United States, and the Medicines and Healthcare products Regulatory Agency of the United Kingdom, and the National Medical Products Administration (NMPA) of China. The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO).

Within the CDSCO, the Drug Controller General of India (DCGI) regulates pharmaceutical and medical devices and is positioning within the Ministry of Health and Family Welfare. The DCGI is advised by the Drug Technical Advisory Board (DTAB) and the Drug Consultative Committee (DCC). Divided into zonal offices, each one carries out pre-licensing and post-licensing inspections, post-market surveillance, and drug recalls (where necessary). Manufacturers who deal with the authority required to name an Authorized Indian Representative (AIR) to represent them in all dealings with the CDSCO in India.

Though the CDSCO has a good track record with the World Health Organization, it has also been accused of past collusion with independent medical experts and pharmaceutical companies. CDSCO plans to open an international office in Beijing, China.

Divisions[edit]

Central Drugs Standard Control Organization has 8 divisions:

  • BA/BE[2]
  • New Drugs[3]
  • Medical Device & Diagnostics[4]
  • DCC-DTAB[5]
  • Import & Registration[6]
  • Biological[7]
  • Cosmetics[8]
  • Clinical Trials[9]

References[edit]

  1. ↑ https://openbudgetsindia.org/dataset?tags=central+drugs+standard+control+organisation
  2. ↑ "BA/BE". cdsco.gov.in. Retrieved 2020-12-29.
  3. ↑ "New Drugs". cdsco.gov.in. Retrieved 2020-12-29.
  4. ↑ "Medical device & diagnostics". cdsco.gov.in. Retrieved 2020-12-29.
  5. ↑ "DTAB-DCC". cdsco.gov.in. Retrieved 2020-12-29.
  6. ↑ "Imports & Registration". cdsco.gov.in. Retrieved 2020-12-29.
  7. ↑ "biologicals". cdsco.gov.in. Retrieved 2020-12-29.
  8. ↑ "cosmetics". cdsco.gov.in. Retrieved 2020-12-29.
  9. ↑ "Committees". cdsco.gov.in. Retrieved 2020-12-29.

External links[edit]

Retrieved from "https://en.bharatpedia.org/index.php?title=Central_Drugs_Standard_Control_Organisation&oldid=162380"